Influence of antibiotics and case exposure on hospital-acquired Clostridium difficile infection independent of illness severity

被引:12
|
作者
Forster, A. J. [1 ,2 ]
Daneman, N. [2 ,3 ]
van Walraven, C. [1 ,2 ]
机构
[1] Univ Ottawa, Ottawa Hosp, Dept Med, Res Inst, Ottawa, ON, Canada
[2] Inst Clin Evaluat Sci, Toronto, ON, Canada
[3] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto Hosp, Toronto, ON, Canada
关键词
Hospital-acquired infection; Clostridium difficile infection; Antibiotics; Competing risks; Time-dependent covariates; Proportional hazards modelling; RISK; TIME; INPATIENT;
D O I
10.1016/j.jhin.2016.10.007
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Previous studies of the association between antibiotic exposure and risk of hospital-acquired Clostridium difficile-associated infection (CDI) have not fully accounted for patient severity of illness, and competing risks. Aim: To determine the potential effects of interventions on hospital-acquired CDI risk. Methods: All adults admitted to a teaching hospital between 2004 and 2014 for more than two days were included. Exposures to all antibiotics and cases of CDI were determined. Patients were followed until discharge from hospital, death, or acquisition of hospitalacquired CDI (defined as positive toxin assay in unformed stool > 2 days following admission). Multivariable proportional hazards competing-risks modelling with time-dependent covariates was used, accounting for patient severity of illness using the Escobar model. Findings: In all, 208,104 patients were studied. Hospital-acquired CDI risk was 0.46 events per 1000 patient-days, decreasing significantly during the study period. Compared to the 5(th) percentile hospital death risk (0.02%), patients with a 50% risk of death in hospital had an adjusted hazard ratio (aHR) of hospital-acquired CDI of 5.5. Exposure to some antibiotics significantly increased hospital-acquired CDI risk, being highest for carbapenems (aHR: 1.47 after one week of continuous exposure) and intravenous vancomycin (aHR: 1.53). On the ward, sharing a room with other patients newly diagnosed with CDI significantly increased the risk of subsequent disease (aHR: 1.16 on CDI diagnosis day). Conclusion: The primary determinant of hospital-acquired CDI was patient severity of illness. Exposure to both antibiotics and other patients with CDI significantly increased the subsequent risk of hospital-acquired CDI but this risk was small relative to patient severity of illness. (C) 2016 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:400 / 409
页数:10
相关论文
共 50 条
  • [41] Obesity Not a Major Risk Factor for Hospital-Acquired Clostridium difficile Infection in Young, African American Males
    Kim, Jeffrey
    Amin, Ankit
    Rossi, James
    Quinn, Andrew J.
    Sellman, Jeffrey
    Vachaparambil, Cicily
    Tomajan, David
    Moore, Deylan
    Saavedra, Sofia
    Goldstein, Neal
    Welles, Seth
    Nandi, Neilanjan
    Kutzler, Michele
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S584 - S584
  • [42] Predictors of Hospital-Acquired Clostridioides difficile Infection: A Systematic Review
    Puro, Neeraj
    Joseph, Reena
    Zengul, Ferhat D.
    Cochran, Kenneth J.
    Camins, Bernard C.
    Ray, Midge
    JOURNAL FOR HEALTHCARE QUALITY, 2020, 42 (03) : 127 - 135
  • [43] The Influence of a Respiratory Viral Infection on Clostridium difficile Infection Severity
    Namn, Yunseok
    Novikov, Aleksey
    Schneider, Yecheskel
    Crawford, Carl V., Jr.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S80 - S80
  • [44] Clostridium Difficile As a Risk Factor For Hospital-Acquired Venous Thrombosis In Medical Inpatients
    Merrill, Samuel A.
    Desarno, Michael
    Houghton, Damon
    Winters, John P., III
    Huston, Christopher
    Callas, Peter
    Repp, Allen B.
    Cushman, Mary
    Zakai, Neil A.
    BLOOD, 2013, 122 (21)
  • [45] PREVENTIVE SCREENING FOR CLOSTRIDIUM DIFFICILE TO REDUCE HOSPITAL-ACQUIRED INFECTIONS IN BMT PATIENTS
    George, Daisy
    Bagwell, Dina
    ONCOLOGY NURSING FORUM, 2024, 51 (02)
  • [46] PROTON PUMP INHIBITORS AND THE RISK FOR HOSPITAL-ACQUIRED CLOSTRIDIUM DIFFICILE IN ICU PATIENTS
    Barletta, Jeffrey
    Sclar, David
    CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [47] COMPREHENSIVE PROGRAM TO REDUCE HOSPITAL-ACQUIRED CLOSTRIDIUM DIFFICILE IN PATIENTS WITH CYSTIC FIBROSIS
    Villarreal, E.
    Horn, C.
    Kuk, K.
    Lozano, R.
    Livingston, M.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S371 - S371
  • [49] A Fulminant Case of Community Acquired Clostridium difficile Infection
    Chela, Harleen
    Atwood, Justin
    Kannuswamy, Rohini
    Collins, Jonathan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S634 - S635
  • [50] Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis
    Arriola, Vanessa
    Tischendorf, Jessica
    Musuuza, Jackson
    Barker, Anna
    Rozelle, Jeffrey W.
    Safdar, Nasia
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2016, 37 (12): : 1408 - 1417